The Effect of Human Papillomavirus Vaccination on Recurrence Rates in HIV Positive Patients Treated for Anal Condylomata.
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Anal cancer; Anal intraepithelial neoplasia; Cervical cancer; Condylomata acuminata; Human papillomavirus infections; Penile cancer
- Focus Therapeutic Use
- 13 Jun 2016 Status changed from recruiting to completed.
- 27 Jul 2009 New trial record